The December 2021 issue of Experimental Medicine, "Bio DX for everyone - Let's Start Treasure Hunting in the Sea of Public Data," planned by Science and Technology Advisor Hidemasa BONO (Project Professor, Graduate School of Integrated Life Sciences, Hiroshima University), is now published.
Keisuke OKUHARA, CEO, and Takashi YAMAMOTO, CTO, wrote the article “Genome editing and Bio-DX to Realize a Bioeconomical Society" about the "Bio×Digital Transformation (BioDX) Industry-Academia Co-Creation Center* to Realize the world's Most Advanced Bioeconomy Society from Hiroshima," which is being promoted mainly by Hiroshima University. Please take a moment to read it.
(* JST "Co-Organization Initiative-Next (COI-NEXT)" adopted project in FY2020)
In addition, an overview by Hidemasa BONO "What is BioDX and Why BioDX Now?" is available in its entirety on the publisher's website. Please take a look at it as well.
<Reference links>
